RxDoctor Payments Data

Robert Lien, NP

Nurse Practitioner · Springfield, MONPI 1821578956

Payments from drug & device makers

$547in general payments, 2019–2025

Across 32 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$144
  • AstraZeneca$138
  • Novo Nordisk$116
  • Sanofi$65
  • Dexcom, Inc.$46
  • Inspire Medical Systems, Inc.$24
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 65th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$62,577
Medicare patients
286
Services billed
2,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide42$54,271
EliquisApixaban61$49,791
XareltoRivaroxaban44$38,825
OzempicSemaglutide33$29,232
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$18,823
JardianceEmpagliflozin12$18,416
FarxigaDapagliflozin Propanediol12$13,456
LinzessLinaclotide14$13,123
Spiriva RespimatTiotropium Bromide12$6,249
Incruse ElliptaUmeclidinium Bromide11$3,830
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$3,530
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$2,862
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$2,733
Gabapentin130$2,373
Atorvastatin Calcium320$2,097

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$144$54,27142 claims
PfizerEliquis$14$49,79161 claims
Novo NordiskOzempic$116$29,23233 claims
AstraZenecaFarxiga$138$13,45612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →